Loading insider details...
Latest Form 4 (Jul 2, 2026): Grant/Award of 36,818 VTGN shares, $7.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Vistagen Therapeutics, Inc. (VTGN) | Grant/Award | 36,818 | $7.1K |
| Apr 10, 2026 | Vistagen Therapeutics, Inc. (VTGN) | Grant/Award | 18,753 | n/a |
| Jul 1, 2025 | Vistagen Therapeutics, Inc. (VTGN) | Grant/Award | 7,541 | $12.8K |
| Jun 25, 2025 | Vistagen Therapeutics, Inc. (VTGN) | Grant/Award | 100,000 | n/a |
| Jul 2, 2024 | Vistagen Therapeutics, Inc. (VTGN) | Grant/Award | 4,854 | $14.4K |
| Jun 27, 2024 | Vistagen Therapeutics, Inc. (VTGN) | Grant/Award | 170,000 | n/a |
| Jan 3, 2024 | Vistagen Therapeutics, Inc. (VTGN) | Grant/Award | 167 | $286.74 |
| Jul 5, 2023 | Vistagen Therapeutics, Inc. (VTGN) | Grant/Award | 167 | $265.45 |
| Aug 19, 2022 | VistaGen Therapeutics, Inc. (VTGN) | Purchase | 300,000 | $50.9K |
| May 3, 2022 | VistaGen Therapeutics, Inc. (VTGN) | Grant/Award | 200,000 | n/a |